Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: Current status and future perspectives

Pulmonary Medicine

Volumn 2014, Issue , 2014, Pages

  Archontogeorgis, Konstantinos ^a   Nena, Evangelia ^a   Papanas, Nikolaos ^a   Steiropoulos, Paschalis ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LEPTIN; MALONALDEHYDE; OXYHEMOGLOBIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; INTERLEUKIN DERIVATIVE;

ARTERIAL WALL THICKNESS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INSULIN RESISTANCE; INTERMITTENT HYPOXIA; METABOLIC SYNDROME X; NIGHT SLEEP; OBESITY; OXIDATIVE STRESS; OXYGEN DESATURATION; OXYGEN SATURATION; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; REVIEW; SLEEP DISORDERED BREATHING; SLEEP TIME; TREATMENT RESPONSE; UPPER AIRWAY RESISTANCE SYNDROME; BLOOD; SLEEP APNEA, OBSTRUCTIVE;

BIOMARKERS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; FIBRINOGEN; HUMANS; INTERLEUKINS; OXIDATIVE STRESS; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84916215073     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2014/930535     Document Type: Review

References (152)

1. American Academy of Sleep Medicine, Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep 1999 22 5 667 689 2-s2.0-0033178851
2. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S., The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine 1993 328 17 1230 1235 2-s2.0-0027462562
3. Peker Y., Hedner J., Norum J., Kraiczi H., Carlson J., Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. The American Journal of Respiratory and Critical Care Medicine 2002 166 2 159 165 10.1164/rccm.2105124 2-s2.0-0037099155
4. Bassetti C. L., Milanova M., Gugger M., Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006 37 4 967 972 10.1161/01.STR.0000208215.49243.c3 2-s2.0-33645830230
5. Shamsuzzaman A. S. M., Gersh B. J., Somers V. K., Obstructive sleep apnea: implications for cardiac and vascular disease. Journal of the American Medical Association 2003 290 14 1906 1914 2-s2.0-0141922797 10.1001/jama.290.14.1906
6. Eisensehr I., Ehrenberg B. L., Noachtar S., Korbett K., Byrne A., McAuley A., Palabrica T., Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998 51 1 188 195 2-s2.0-0031814516 10.1212/WNL.51.1.188
7. Stiefel P., Sánchez-Armengol M. A., Villar J., Vallejo-Vaz A., Moreno-Luna R., Capote F., Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles. Archives of Medical Research 2013 44 6 409 414 2-s2.0-84885102238 10.1016/j.arcmed.2013.08.005
8. Silverberg D. S., Oksenberg A., Iaina A., Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. The American Journal of Hypertension 1997 10 12, part 1 1319 1325 2-s2.0-0031408338 10.1016/S0895-7061(97)00322-1
9. Atkinson A. J., Colburn W. A., DeGruttola V. G., Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics 2001 69 3 89 95 2-s2.0-0035100888 10.1067/mcp.2001.113989
10. Shih J. L., Malhotra A., Could vitamins be helpful to patients with sleep apnea? Chest 2011 139 2 237 238 10.1378/chest.10-2017 2-s2.0-79551575157
11. Mullington J. M., Haack M., Toth M., Serrador J. M., Meier-Ewert H. K., Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Progress in Cardiovascular Diseases 2009 51 4 294 302 2-s2.0-57749110820 10.1016/j.pcad.2008.10.003
12. Patel S. R., Zhu X., Storfer-Isser A., Mehra R., Jenny N. S., Tracy R., Redline S., Sleep duration and biomarkers of inflammation. Sleep 2009 32 2 200 204 2-s2.0-62549120766
13. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D. R., Miles J. M., Yudkin J. S., Klein S., Coppack S. W., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor- α in vivo. The Journal of Clinical Endocrinology and Metabolism 1997 82 12 4196 4200 2-s2.0-0030735542
14. Bruun J. M., Pedersen S. B., Richelsen B., Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. The Journal of Clinical Endocrinology and Metabolism 2001 86 3 1267 1273 2-s2.0-0035048514 10.1210/jc.86.3.1267
15. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- α in human obesity and insulin resistance. The Journal of Clinical Investigation 1995 95 5 2409 2415 10.1172/JCI117936 2-s2.0-0028931724
16. Alvarado M. M. R., Roitz C. S., Relation of serum levels of C-reactive protein to anthropometric meaurements; a sustematic review of studies in South America. Nutricion Hospitalaria 2012 27 4 971 977 10.3305/nh.2012.27.4.5792 2-s2.0-84864306551
17. Pasceri V., Chang J., Willerson J. T., Yeh E. T. H., Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001 103 21 2531 2534 10.1161/01.CIR.103.21.2531 2-s2.0-0035967470
18. Ridker P. M., Buring J. E., Shih J., Matias M., Hennekens C. H., Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998 98 8 731 733 10.1161/01.CIR.98.8.731 2-s2.0-0032566401
19. Heeschen C., Hamm C. W., Bruemmer J., Simoons M. L., Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. Journal of the American College of Cardiology 2000 35 6 1535 1542 10.1016/S0735-1097(00)00581-7 2-s2.0-0034111390
20. Sahlman J., Miettinen K., Peuhkurinen K., Seppä J., Peltonen M., Herder C., Punnonen K., Vanninen E., Gylling H., Partinen M., Uusitupa M., Tuomilehto H., The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea: Sleep apnea and inflammation. Journal of Sleep Research 2010 19 2 341 348 2-s2.0-77952618489 10.1111/j.1365-2869.2009.00787.x
21. Shamsuzzaman A. S. M., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., Somers V. K., Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002 105 21 2462 2464 10.1161/01.CIR.0000018948.95175.03 2-s2.0-0037188605
22. Hayashi M., Fujimoto K., Urushibata K., Takamizawa A., Kinoshita O., Kubo K., Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology 2006 11 1 24 31 10.1111/j.1440-1843.2006.00780.x 2-s2.0-33645107179
23. Steiropoulos P., Papanas N., Nena E., Antoniadou M., Serasli E., Papoti S., Hatzizisi O., Kyriazis G., Tzouvelekis A., Maltezos E., Tsara V., Bouros D., Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators of Inflammation 2010 2010 6 675320 10.1155/2010/675320 2-s2.0-77954551400
24. Guven S. F., Turkkani M. H., Ciftci B., Ciftci T. U., Erdogan Y., The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep and Breathing 2012 16 1 217 221 10.1007/s11325-011-0492-2 2-s2.0-84859163184
25. Hall T. S., Herrscher T. E., Jarolim P., Fagerland M. W., Jensen T., Agewall S., Atar D., Hallén J., Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea. Sleep Medicine 2014 15 762 768 10.1016/j.sleep.2014.03.008 2-s2.0-84900358247
26. Yokoe T., Minoguchi K., Matsuo H., Oda N., Minoguchi H., Yoshino G., Hirano T., Adachi M., Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003 107 8 1129 1134 10.1161/01.CIR.0000052627.99976.18 2-s2.0-0037418181
27. Steiropoulos P., Tsara V., Nena E., Fitili C., Kataropoulou M., Froudarakis M., Christaki P., Bouros D., Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2007 132 3 843 851 10.1378/chest.07-0074 2-s2.0-35448991656
28. Kohler M., Ayers L., Pepperell J. C. T., Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009 64 1 67 73 10.1136/thx.2008.097931 2-s2.0-58349091877
29. Baessler A., Nadeem R., Harvey M., Madbouly E., Younus A., Sajid H., Naseem J., Asif A., Bawaadam H., Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers-a meta-analysis. Journal of Inflammation 2013 10 1 13 10.1186/1476-9255-10-13 2-s2.0-84875182830
30. Nadeem R., Molnar J., Madbouly E. M., Nida M., Aggarwal S., Sajid H., Naseem J., Loomba R., Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. Journal of Clinical Sleep Medicine 2013 9 10 1003 1012 10.5664/jcsm.3070 2-s2.0-84888188114
31. Guilleminault C., Kirisoglu C., Ohayon M. M., C-reactive protein and sleep-disordered breathing. Sleep 2004 27 8 1507 1511 2-s2.0-11144256430
32. Ryan S., Nolan G. M., Hannigan E., Cunningham S., Taylor C., McNicholas W. T., Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007 62 6 509 514 10.1136/thx.2006.066720 2-s2.0-34250339549
33. Arnardottir E. S., Maislin G., Schwab R. J., The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012 35 7 921 932 10.5665/sleep.1952 2-s2.0-84863226146
34. Idriss H. T., Naismith J. H., TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microscopy Research and Technique 2000 50 3 184 195
35. Vgontzas A. N., Papanicolaou D. A., Bixler E. O., Kales A., Tyson K., Chrousos G. P., Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. Journal of Clinical Endocrinology and Metabolism 1997 82 5 1313 1316 10.1210/jcem.82.5.3950 2-s2.0-0030989915
36. Minoguchi K., Tazaki T., Yokoe T., Elevated production of tumor necrosis factor- α by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004 126 5 1473 1479 10.1378/chest.126.5.1473 2-s2.0-8744224469
37. Kanbay A., Kokturk O., Ciftci T. U., Tavil Y., Bukan N., Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration 2008 76 3 324 330 10.1159/000134010 2-s2.0-53149114884
38. Liu H., Liu J., Xiong S., Shen G., Zhang Z., Xu Y., The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. Journal of Tongji Medical University 2000 20 3 200 202 2-s2.0-0034572063
39. Ciftci T. U., Kokturk O., Bukan N., Bilgihan A., The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004 28 2 87 91 10.1016/j.cyto.2004.07.003 2-s2.0-4644288261
40. Ciccone M. M., Scicchitano P., Zito A., Cortese F., Boninfante B., Falcone V. A., Quaranta V. N., Ventura V. A., Zucano A., Di Serio F., Damiani M. F., Resta O., Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 2014 19 2 1651 1662 10.3390/molecules19021651 2-s2.0-84894616380
41. Steiropoulos P., Kotsianidis I., Nena E., Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 2009 32 4 537 543 2-s2.0-65249129771
42. Hegglin A., Schoch O. D., Korte W., Hahn K., Hürny C., Münzer T., Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome. Sleep and Breathing 2012 16 2 405 412 10.1007/s11325-011-0512-2 2-s2.0-84861480831
43. Imagawa S., Yamaguchi Y., Ogawa K., Obara N., Suzuki N., Yamamoto M., Nagasawa T., Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration 2004 71 1 24 29 10.1159/000075645 2-s2.0-1242306602
44. Guasti L., Marino F., Cosentino M., Maroni L., Maresca A. M., Colombo F., Maio R. C., Castiglioni L., Saporiti F., Loraschi A., Gaudio G., Bernasconi A., Laurita E., Grandi A. M., Venco A., Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. Sleep & Breathing 2011 15 1 3 11 2-s2.0-79958096953 10.1007/s11325-009-0315-x
45. Fantuzzi G., Adipose tissue, adipokines, and inflammation. The Journal of Allergy and Clinical Immunology 2005 115 5 911 920 10.1016/j.jaci.2005.02.023 2-s2.0-18144408371
46. Hedges J. C., Singer C. A., Gerthoffer W. T., Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. The American Journal of Respiratory Cell and Molecular Biology 2000 23 1 86 94 10.1165/ajrcmb.23.1.4014 2-s2.0-0033887184
47. Hirani N., Antonicelli F., Strieter R. M., Wiesener M. S., Haslett C., Donnelly S. C., The regulation of interleukin-8 by hypoxia in human macrophages-a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Molecular Medicine 2001 7 10 685 697 2-s2.0-0035174962
48. Ohga E., Tomita T., Wada H., Yamamoto H., Nagase T., Ouchi Y., Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. Journal of Applied Physiology 2003 94 1 179 184 2-s2.0-0037215191
49. Oyama J.-I., Yamamoto H., Maeda T., Ito A., Node K., Makino N., Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clinical Cardiology 2012 35 4 231 236 10.1002/clc.21010 2-s2.0-84859766047
50. Alzoghaibi M. A., BaHammam A. S., Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep & Breathing 2005 9 3 119 126 2-s2.0-33745901383 10.1007/s11325-005-0022-1
51. Tamisier R., Pépin J. L., Rémy J., Baguet J. P., Taylor J. A., Weiss J. W., Lévy P., 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. The European Respiratory Journal 2011 37 1 119 128 2-s2.0-79251540222 10.1183/09031936.00204209
52. Yudkin J. S., Kumari M., Humphries S. E., Mohamed-Ali V., Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000 148 2 209 214 10.1016/S0021-9150(99)00463-3 2-s2.0-0033984744
53. Bastard J.-P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., Capeau J., Feve B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 2006 17 1 4 12 2-s2.0-33745896155
54. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 5 2273 2282 2-s2.0-2042480671 10.1210/en.2003-1336
55. Maeder M. T., Strobel W., Christ M., Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clinical Biochemistry 2014 10.1016/j.clinbiochem.2014.09.005
56. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 6423 801 809 10.1038/362801a0 2-s2.0-0027241856
57. Pober J. S., Gimbrone M. A. Jr., Lapierre L. A., Mendrick D. L., Fiers W., Rothlein R., Springer T. A., Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. Journal of Immunology 1986 137 6 1893 1896 2-s2.0-0022508185
58. Amberger A., Maczek C., Jurgens G., Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress & Chaperones 1997 2 2 94 103
59. Smith C. W., Rothlein R., Hughes B. J., Mariscalco M. M., Rudloff H. E., Schmalstieg F. C., Anderson D. C., Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. The Journal of Clinical Investigation 1988 82 5 1746 1756 2-s2.0-0024266620 10.1172/JCI113788
60. Ginis I., Mentzer S. J., Faller D. V., Hypoxia induces lymphocyte adhesion to human mesenchymal cells via an LFA- 1-dependent mechanism. The American Journal of Physiology-Cell Physiology 1993 264 3, part 1 C617 C624 2-s2.0-0027526369
61. Cofta S., Wysocka E., Dziegielewska-Gesiak S., Michalak S., Piorunek T., Batura-Gabryel H., Torlinski L., Plasma selectins in patients with obstructive sleep apnea. Advances in Experimental Medicine and Biology 2013 756 113 119 10.1007/978-94-007-4549-0-15 2-s2.0-84867551141
62. Testelmans D., Tamisier R., Barone-rochette G., Baguet J.-P., Roux-Lombard P., Pépin J.-L., Lévy P., Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events. Cytokine 2013 62 2 210 216 10.1016/j.cyto.2013.02.021 2-s2.0-84876797630
63. Querido J. S., Sheel A. W., Cheema R., Eeden S. V., Mulgrew A. T., Ayas N. T., Effects of 10 days of modest intermittent hypoxia on circulating measures of inflammation in healthy humans. Sleep and Breathing 2012 16 3 657 662 2-s2.0-84867574767 10.1007/s11325-011-0555-4
64. Ursavas A., Karadag M., Rodoplu E., Yilmaztepe A., Oral H. B., Gozu R. O., Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 2007 74 5 525 532 10.1159/000097770 2-s2.0-34547624101
65. Ohga E., Nagase T., Tomita T., Teramoto S., Matsuse T., Katayama H., Ouchi Y., Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. Journal of Applied Physiology 1999 87 1 10 14 2-s2.0-0032799263
66. El-Solh A. A., Mador M. J., Sikka P., Dhillon R. S., Amsterdam D., Grant B. J. B., Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002 121 5 1541 1547 10.1378/chest.121.5.1541 2-s2.0-0036247736
67. Chin K., Nakamura T., Shimizu K., Mishima M., Miyasaka M., Ohi M., Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. The American Journal of Medicine 2000 109 7 562 567 10.1016/S0002-9343(00)00580-5 2-s2.0-0033765734
68. Ridker P. M., Role of inflammatory biomarkers in prediction of coronary heart disease. The Lancet 2001 358 9286 946 948 10.1016/S0140-6736(01)06112-8 2-s2.0-0035934563
69. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G., Fibrinogen as a risk factor for stroke and myocardial infarction. The New England Journal of Medicine 1984 311 8 501 505 10.1056/NEJM198408233110804 2-s2.0-0021210911
70. Wessendorf T. E., Thilmann A. F., Wang Y.-M., Schreiber A., Konietzko N., Teschler H., Fibrinogen levels and obstructive sleep apnea in ischemic stroke. The American Journal of Respiratory and Critical Care Medicine 2000 162 6 2039 2042 10.1164/ajrccm.162.6.2001048 2-s2.0-0034520051
71. Nobili L., Schiavi G., Bozano E., de Carli F., Ferrillo F., Nobili F., Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clinical Hemorheology and Microcirculation 2000 22 1 21 27 2-s2.0-0034050536
72. Imoberdorf R., Garlick P. J., Mcnurlan M. A., Casella G. A., Peheim E., Turgay M., Bärtsch P., Ballmer P. E., Enhanced synthesis of albumin and fibrinogen at high altitude. Journal of Applied Physiology 2001 90 2 528 537 2-s2.0-0035143638
73. Chin K., Ohi M., Kita H., Noguchi T., Otsuka N., Tsuboi T., Mishima M., Kuno K., Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. The American Journal of Respiratory and Critical Care Medicine 1996 153 6, part 1 1972 1976 10.1164/ajrccm.153.6.8665063 2-s2.0-0029951897
74. Basoglu O. K., Sarac F., Sarac S., Uluer H., Yilmaz C., Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Annals of Thoracic Medicine 2011 6 3 120 125 2-s2.0-80052905030 10.4103/1817-1737.82440
75. Steiner S., Jax T., Evers S., Hennersdorf M., Schwalen A., Strauer B. E., Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005 104 2 92 96 2-s2.0-23944511645 10.1159/000086729
76. Shamsuzzaman A., Amin R. S., Calvin A. D., Davison D., Somers V. K., Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep and Breathing 2014 2-s2.0-84893201513 10.1007/s11325-014-0938-4
77. von Känel R., Dimsdale J. E., Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003 124 5 1956 1967 10.1378/chest.124.5.1956 2-s2.0-10744229839
78. Kaditis A. G., Alexopoulos E. I., Kalampouka E., Kostadima E., Angelopoulos N., Germenis A., Zintzaras E., Gourgoulianis K., Morning levels of fibrinogen in children with sleep-disordered breathing. European Respiratory Journal 2004 24 5 790 797 10.1183/09031936.04.00009804 2-s2.0-8644252664
79. Krobot K., Hense H. W., Cremer P., Eberle E., Keil U., Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex: results from the second MONICA Augsburg survey, 1989-1990. Arteriosclerosis and Thrombosis 1992 12 7 780 788 2-s2.0-0026650534
80. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology 2007 39 1 44 84 10.1016/j.biocel.2006.07.001 2-s2.0-33749986298
81. Lavie L., Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Progress in Cardiovascular Diseases 2009 51 4 303 312 10.1016/j.pcad.2008.08.003 2-s2.0-57749100366
82. McCord J. M., Oxygen-derived free radicals in postischemic tissue injury. The New England Journal of Medicine 1985 312 3 159 163 10.1056/NEJM198501173120305 2-s2.0-0021984681
83. Katsoulis K., Kontakiotis T., Spanogiannis D., Vlachogiannis E., Kougioulis M., Gerou S., Daskalopoulou E., Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease. Sleep & Breathing 2011 15 4 861 866 10.1007/s11325-010-0456-y 2-s2.0-84859385971
84. Lee S. D., Ju G., Choi J.-A., Kim J.-W., Yoon I.-Y., The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep and Breathing 2012 16 2 511 517 10.1007/s11325-011-0536-7 2-s2.0-84861480893
85. Simiakakis M., Kapsimalis F., Chaligiannis E., Loukides S., Sitaras N., Alchanatis M., Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients. PLoS ONE 2012 7 6 e39172 10.1371/journal.pone.0039172 2-s2.0-84862698813
86. Morrow J. D., Roberts L. J., The isoprostanes: unique bioactive products of lipid peroxidation. Progress in Lipid Research 1997 36 1 1 21 10.1016/S0163-7827(97)00001-5 2-s2.0-0030963753
87. Tan K. C., Chow W.-S., Lam J. C., Lam B., Wong W.-K., Tam S., Ip M. S. M., HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006 184 2 377 382 10.1016/j.atherosclerosis.2005.04.024 2-s2.0-30044437707
88. Barceló A., Piérola J., De La Peña M., Esquinas C., Fuster A., Sanchez-de-la-Torre M., Carrera M., Alonso-Fernandez A., Ladaria A., Bosch M., Barbé F., Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. European Respiratory Journal 2011 37 6 1418 1423 10.1183/09031936.00050410 2-s2.0-79958007214
89. Alonso-Fernández A., García-Río F., Arias M. A., Hernanz Á., De La Peña M., Piérola J., Barceló A., López-Collazo E., Agustí A., Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009 64 7 581 586 10.1136/thx.2008.100537 2-s2.0-67650245608
90. Svatikova A., Wolk R., Lerman L. O., Juncos L. A., Greene E. L., McConnell J. P., Somers V. K., Oxidative stress in obstructive sleep apnoea. European Heart Journal 2005 26 22 2435 2439 10.1093/eurheartj/ehi440 2-s2.0-27644451715
91. Tsimikas S., Willeit P., Willeit J., Santer P., Mayr M., Xu Q., Mayr A., Witztum J. L., Kiechl S., Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. Journal of the American College of Cardiology 2012 60 21 2218 2229 10.1016/j.jacc.2012.08.979 2-s2.0-84869090395
92. Mehmetcik G., Ozdemirler G., Kanbagli O., Toker G., Uysal M., Age-related changes in plasma lipid peroxidation and antioxidant system in humans and rats. Archives of Gerontology and Geriatrics 1997 25 3 305 310 10.1016/S0167-4943(97)00023-X 2-s2.0-0343487684
93. Dorkova Z., Petrasova D., Molcanyiova A., Popovnakova M., Tkacova R., Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008 134 4 686 692 10.1378/chest.08-0556 2-s2.0-54249085473
94. Vatansever E., Surmen-Gur E., Ursavas A., Karadag M., Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep & Breathing 2011 15 3 275 282 10.1007/s11325-010-0378-8 2-s2.0-80054929356
95. Jurado-Gámez B., Fernandez-Marin M. C., Gómez-Chaparro J. L., Muñoz-Cabrera L., Lopez-Barea J., Perez-Jimenez F., Lopez-Miranda J., Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. The European Respiratory Journal 2011 37 4 873 879 10.1183/09031936.00027910 2-s2.0-79953695110
96. Barcelo A., Miralles C., Barbe F., Vila M., Pons S., Agusti A. G. N., Abnormal lipid peroxidation in patients with sleep apnoea. European Respiratory Journal 2000 16 4 644 647 10.1034/j.1399-3003.2000.16d13.x 2-s2.0-0033777033
97. Jordan W., Cohrs S., Degner D., Meier A., Rodenbeck A., Mayer G., Pilz J., Rüther E., Kornhuber J., Bleich S., Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. Journal of Neural Transmission 2006 113 2 239 254 10.1007/s00702-005-0316-2 2-s2.0-31044451221
98. Cofta S., Wysocka E., Michalak S., Piorunek T., Batura-Gabryel H., Torlinski L., Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males. European Journal of Medical Research 2009 14 supplement 4 49 52 2-s2.0-77955489888 10.1186/2047-783X-14-S4-49
99. Baysal E., Taysi S., Aksoy N., Uyar M., Çelenk F., Karatas Z. A., Tarakcioglu M., Bilinç H., Mumbuç S., Kanlikama M., Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). European Review for Medical and Pharmacological Sciences 2012 16 6 770 774 2-s2.0-84864263316
100. Bekci T. T., Kayrak M., Kiyici A., Maden E., Ari H., Kaya Z., Teke T., Akilli H., The association among lipoprotein-associated phospholipase A2 levels, total antioxidant capacity and arousal in male patients with OSA. International Journal of Medical Sciences 2011 8 5 369 376 2-s2.0-84860409411
101. Ntalapascha M., Makris D., Kyparos A., Tsilioni I., Kostikas K., Gourgoulianis K., Kouretas D., Zakynthinos E., Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep & Breathing 2013 17 2 549 555 10.1007/s11325-012-0718-y 2-s2.0-84878013207
102. Goswami B., Tayal D., Gupta N., Mallika V., Paraoxonase: a multifaceted biomolecule. Clinica Chimica Acta 2009 410 1-2 1 12 10.1016/j.cca.2009.09.025 2-s2.0-70350567789
103. Lavie L., Vishnevsky A., Lavie P., Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004 27 1 123 128 2-s2.0-2442674412
104. Lavie L., Dyugovskaya L., Golan-Shany O., Lavie P., Heat-shock protein 70: expression in monocytes of patients with sleep apnoea and association with oxidative stress and tumour necrosis factor- α Journal of Sleep Research 2010 19 1 139 147 10.1111/j.1365-2869.2009.00789.x 2-s2.0-77950659336
105. Okur H. K., Pelin Z., Yuksel M., Yosunkaya S., Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia. Sleep & Breathing 2013 17 1 365 371 10.1007/s11325-012-0703-5 2-s2.0-84874190327
106. Kotani K., Kimura S., Tsuzaki K., Reduced paraoxonase 1/arylesterase activity and its post-therapeutic increase in obstructive sleep apnea syndrome: a preliminary study. Clinica Chimica Acta 2008 395 1-2 184 185 10.1016/j.cca.2008.04.023 2-s2.0-47649115894
107. Vgontzas A. N., Bixler E. O., Chrousos G. P., Sleep apnea is a manifestation of the metabolic syndrome. Sleep Medicine Reviews 2005 9 3 211 224 10.1016/j.smrv.2005.01.006 2-s2.0-18844378616
108. Punjabi N. M., Sorkin J. D., Katzel L. I., Goldberg A. P., Schwartz A. R., Smith P. L., Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. The American Journal of Respiratory and Critical Care Medicine 2002 165 5 677 682 10.1164/ajrccm.165.5.2104087 2-s2.0-0036499751
109. Sökücü S. N., Karasulu L., Dalar L., Özdemir C., Seyhan E. C., Aydin Ş., Altin S., Effect of hypoxia on glucose methabolism in nondiabetic patients with obstructive sleep apnea syndrome. Archivos de Bronconeumologia 2013 49 8 321 325 2-s2.0-84881024436 10.1016/j.arbres.2013.01.006
110. Koren D., Katz L. E. L., Brar P. C., Gallagher P. R., Berkowitz R. I., Brooks L. J., Sleep architecture and glucose and insulin homeostasis in obese adolescents. Diabetes Care 2011 34 11 2442 2447 10.2337/dc11-1093 2-s2.0-84857096703
111. Tamura A., Kawano Y., Watanabe T., Kadota J., Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Medicine 2012 13 8 1050 1055 2-s2.0-84865281664 10.1016/j.sleep.2012.04.007
112. Hermans M. P., Ahn S. A., Mahadeb Y. P., Rousseau M. F., Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance. Diabetes/Metabolism Research and Reviews 2013 29 3 227 234 10.1002/dmrr.2387 2-s2.0-84875033070
113. Priou P., le Vaillant M., Meslier N., Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes. Diabetes Care 2012 35 9 1902 1906 10.2337/dc11-2538 2-s2.0-84865498319
114. Papanas N., Steiropoulos P., Nena E., Tzouvelekis A., Maltezos E., Trakada G., Bouros D., HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vascular Health and Risk Management 2009 5 751 756 2-s2.0-74049144586
115. Steiropoulos P., Papanas N., Nena E., Tsara V., Fitili C., Tzouvelekis A., Christaki P., Maltezos E., Bouros D., Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control? Sleep Medicine 2009 10 8 887 891 10.1016/j.sleep.2008.10.004 2-s2.0-68749105786
116. Chakhtoura M., Azar S. T., Continuous positive airway pressure and type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research and Reviews 2012 6 3 176 179 10.1016/j.dsx.2012.09.013 2-s2.0-84869503144
117. 1c in patients with obstructive sleep apnea: a systematic review and meta-analysis. Lung 2012 190 6 605 611 10.1007/s00408-012-9404-x 2-s2.0-84874420147
118. Yang D., Liu Z., Yang H., Luo Q., Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep & Breathing 2013 17 1 33 38 10.1007/s11325-012-0680-8 2-s2.0-84874194474
119. Hecht L., Möhler R., Meyer G., Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. German Medical Science 2011 9, article Doc20 2-s2.0-84855177087
120. Friedman J. M., Leptin and the regulation of body weigh. The Keio Journal of Medicine 2011 60 1 1 9 10.2302/kjm.60.1 2-s2.0-79955701330
121. Hargens T. A., Guill S. G., Kaleth A. S., Nickols-Richardson S. M., Miller L. E., Zedalis D., Gregg J. M., Gwazdauskas F., Herbert W. G., Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep & Breathing 2013 17 1 403 409 10.1007/s11325-012-0708-0 2-s2.0-84874194551
122. Tokuda F., Sando Y., Matsui H., Koike H., Yokoyama T., Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Internal Medicine 2008 47 21 1843 1849 10.2169/internalmedicine.47.1035 2-s2.0-56349116660
123. Garcia J. M., Sharafkhaneh H., Hirshkowitz M., Elkhatib R., Sharafkhaneh A., Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respiratory Research 2011 12, article 80 10.1186/1465-9921-12-80 2-s2.0-79958773052
124. Sánchez-de-la-Torre M., Mediano O., Barcelo A., Piérola J., Peña M. D. L., Esquinas C., Miro A., Durán-Cantolla J., Agustí A. G., Capote F., Marin J. M., Montserrat J. M., García-Río F., Barbá F., The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep and Breathing 2012 16 3 649 656 2-s2.0-84867576266 10.1007/s11325-011-0552-7
125. Vettor R., Milan G., Rossato M., Federspil G., Review article: adipocytokines and insulin resistance. Alimentary Pharmacology & Therapeutics 2005 22 supplement 2 3 10 10.1111/j.1365-2036.2005.02587.x 2-s2.0-27644509152
126. Lam J. C., Xu A., Tam S., Khong P.-L., Yao T.-J., Lam D. C. L., Lai A. Y. K., Lam B., Lam K. S. L., Ip M. S. M., Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 2008 31 12 1721 1727 2-s2.0-57349137161
127. Nakagawa Y., Kishida K., Kihara S., Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome. American Journal of Physiology-Endocrinology and Metabolism 2008 294 4 E778 E784 10.1152/ajpendo.00709.2007 2-s2.0-41649084757
128. Zhang X.-L., Yin K.-S., Wang H., Su S., Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 2006 73 1 73 77 10.1159/000088690 2-s2.0-33644515685
129. Kim J., Lee C. H., Park C. S., Kim B. G., Kim S. W., Cho J. H., Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome. Archives of Otolaryngology-Head and Neck Surgery 2010 136 9 896 899 2-s2.0-77957032026 10.1001/archoto.2010.142
130. Harsch I. A., Wallaschofski H., Koebnick C., Pour Schahin S., Hahn E. G., Ficker J. H., Lohmann T., Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 2004 71 6 580 586 10.1159/000081758 2-s2.0-11844258841
131. de Lima A. M. J., Franco C. M. R., de Castro C. M. M. B., Bezerra A. D. A., Ataíde L. Jr., Halpern A., Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 2010 79 5 370 376 2-s2.0-77951298524 10.1159/000227800
132. Zhang X.-L., Yin K.-S., Li C., Jia E.-Z., Li Y.-Q., Gao Z.-F., Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome. Chinese Medical Journal 2007 120 17 1477 1481 2-s2.0-34848855726
133. Degawa-Yamauchi M., Bovenkerk J. E., Juliar B. E., Watson W., Kerr K., Jones R., Zhu Q., Considine R. V., Serum resistin (FIZZ3) protein is increased in obese humans. The Journal of Clinical Endocrinology and Metabolism 2003 88 11 5452 5455 10.1210/jc.2002-021808 2-s2.0-0344874247
134. Silha J. V., Krsek M., Skrha J. V., Sucharda P., Nyomba B. L. G., Murphy L. J., Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistence. European Journal of Endocrinology 2003 149 4 331 335 2-s2.0-0142216501 10.1530/eje.0.1490331
135. Yamamoto Y., Fujiuchi S., Hiramatsu M., Nishigaki Y., Takeda A., Fujita Y., Yamazaki Y., Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 2008 76 4 377 385 10.1159/000141866 2-s2.0-56649098780
136. Harsch I. A., Koebnick C., Wallaschofski H., Schahin S. P., Hahn E. G., Ficker J. H., Lohmann T., Konturek P. C., Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation? Medical Science Monitor 2004 10 9 CR510 CR515 2-s2.0-4644285153
137. Yim-Yeh S., Rahangdale S., Nguyen A. T. D., E. Stevenson K., Novack V., Veves A., Malhotra A., Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus. Obesity 2011 19 1 17 22 10.1038/oby.2010.116 2-s2.0-78650680212
138. Dollery C. M., McEwan J. R., Henney A. M., Matrix metalloproteinases and cardiovascular disease. Circulation Research 1995 77 5 863 868 10.1161/01.RES.77.5.863 2-s2.0-0028792509
139. Kondo S., Kubota S., Shimo T., Nishida T., Yosimichi G., Eguchi T., Sugahara T., Takigawa M., Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002 23 5 769 776 10.1093/carcin/23.5.769 2-s2.0-0036262188
140. Volná J., Kemlink D., Kalousová M., Vávrová J., Majerová V., Mestek O., Švarcová J., Šonka K., Zima T., Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Medical Science Monitor 2011 17 9 CR491 CR497 2-s2.0-80054038560
141. Tazaki T., Minoguchi K., Yokoe T., Samson K. T. R., Minoguchi H., Tanaka A., Watanabe Y., Adachi M., Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. American Journal of Respiratory and Critical Care Medicine 2004 170 12 1354 1359 10.1164/rccm.200402-193OC 2-s2.0-10644258729
142. Vuralkan E., Mutlu M., Firat I. H., Akaydin S., Sagit M., Akin I., Miser E., Ardic S., Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS. European Archives of Oto-Rhino-Laryngology 2014 271 5 1329 1334 10.1007/s00405-013-2821-5 2-s2.0-84898903285
143. Kondo N., Ishii Y., Kwon Y.-W., Tanito M., Horita H., Nishinaka Y., Nakamura H., Yodoi J., Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. Journal of Immunology 2004 172 1 442 448 10.4049/jimmunol.172.1.442 2-s2.0-0346103718
144. Zhou W., Li S., Wan N., Zhang Z., Guo R., Chen B., Effects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissues. Respirology 2012 17 5 821 829 10.1111/j.1440-1843.2012.02157.x 2-s2.0-84862997325
145. Kim J., Bhattacharjee R., Dayyat E., Snow A. B., Kheirandish-Gozal L., Goldman J. L., Li R. C., Serpero L. D., Clair H. B., Gozal D., Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatric Research 2009 66 4 423 428 10.1203/PDR.0b013e3181b453e3 2-s2.0-70350444965
146. Takahashi K.-I., Chin K., Nakamura H., Morita S., Sumi K., Oga T., Matsumoto H., Niimi A., Fukuhara S., Yodoi J., Mishima M., Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxidants and Redox Signaling 2008 10 4 715 726 10.1089/ars.2007.1949 2-s2.0-38949207976
147. Guo Q., Wang Y., Li Q. Y., Li M., Wan H. Y., Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep and Breathing 2013 17 1 311 316 10.1007/s11325-012-0692-4 2-s2.0-84874192025
148. Özkan Y., Özkan E., Imşek B., Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. International Journal of Cardiology 2002 82 3 269 277 10.1016/S0167-5273(02)00010-4 2-s2.0-0036126402
149. Cintra F., Tufik S., D'Almeida V., Calegare B. F. A., De Paola A., Oliveira W., Rizzi C., Roizenblatt S., Poyares D., Cysteine: a potential biomarker for obstructive sleep apnea. Chest 2011 139 2 246 252 2-s2.0-79551585992 10.1378/chest.10-0667
150. Kanbay A., Hasanoglu H. C., A new prognostic marker for obstructive sleep apnea: hepcidin. Medical Hypotheses 2007 69 6 1381 1382 10.1016/j.mehy.2007.03.016 2-s2.0-35448990930
151. Bonsignore M. R., Zito A., Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk. Archives of Physiology and Biochemistry 2008 114 4 255 260 10.1080/13813450802307451 2-s2.0-54349109359
152. Gozal D., Jortani S., Snow A. B., Kheirandish-Gozal L., Bhattacharjee R., Kim J., Capdevila O. S., Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. The American Journal of Respiratory and Critical Care Medicine 2009 180 12 1253 1261 10.1164/rccm.200905-0765OC 2-s2.0-72549085929